An Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2
Authors:
Open Access
- 1 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 29 (9) , 1950-1959
Abstract
: Recombinant bone morphogenetic protein 2 (rhBMP2) has been used clinically to treat bone fractures in human patients. However, the high doses of rhBMP2 required for a therapeutic response can cause undesirable side effects. Here, we demonstrate that a novel Activin A/BMP2 (AB2) chimera, AB204, promotes osteogenesis and bone healing much more potently and effectively than rhBMP2. Remarkably, 1 month of AB204 treatment completely heals tibial and calvarial defects of critical size in mice at a concentration 10-fold lower than a dose of rhBMP2 that only partially heals the defect. We determine the structure of AB204 to 2.3 Å that reveals a distinct BMP2-like fold in which the Activin A sequence segments confer insensitivity to the BMP2 antagonist Noggin and an affinity for the Activin/BMP type II receptor ActRII that is 100-fold greater than that of BMP2. The structure also led to our identification of a single Activin A-derived amino acid residue, which, when mutated to the corresponding BMP2 residue, resulted in a significant increase in the affinity of AB204 for its type I receptor BMPRIa and a further enhancement in AB204's osteogenic potency. Together, these findings demonstrate that rationally designed AB2 chimeras can provide BMP2 substitutes with enhanced potency for treating non-union bone fractures. © 2014 American Society for Bone and Mineral Research.Keywords
This publication has 35 references indexed in Scilit:
- TGF-β and BMP Signaling in Osteoblast Differentiation and Bone FormationInternational Journal of Biological Sciences, 2012
- Designer TGFβ Superfamily Ligands with Diversified FunctionalityPLOS ONE, 2011
- High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In VivoTissue Engineering Part A, 2011
- REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D Structural Biology, 2011
- Mesenchymal Stem Cells Expressing Osteogenic and Angiogenic Factors Synergistically Enhance Bone Formation in a Mouse Model of Segmental Bone DefectMolecular Therapy, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Structure of the ternary signaling complex of a TGF-β superfamily memberProceedings of the National Academy of Sciences, 2006
- Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution 1 1Edited by R. HuberJournal of Molecular Biology, 1999
- Serine/threonine kinase receptorsProgress in Growth Factor Research, 1994